Specialities

Specialities

Acne
Aesthetic Dermatology
Allergic Conditions
Alopecia Areata
Autoimmune Diseases
Dermatitis
Dermato-oncology
Dermatological Disorders
Dermatological Surgery
Epidermolysis Bullosa
Hidradenitis Suppurativa
Infectious Diseases
Paediatric Dermatology
Pigmentation Disorders
Prurigo Nodularis
Psoriasis
Rare Diseases
Rosacea
Scars
Teledermatology
Urticaria
Search

Trending Topic

bullous pemphigoid
2 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

How dupilumab is set to transform bullous pemphigoid treatment

Dedee Murrell

    The FDA approval of dupilumab represents a major step forward for adults living with bullous pemphigoid (BP), one that is likely to transform how we manage this chronic autoimmune blistering condition. Dupilumab, a monoclonal antibody that blocks IL-4Rα and inhibits IL-4 and IL-13 signalling, is the first targeted therapy approved for bullous pemphigoid. […]

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Society & Congress Partners

touchDERMATOLOGY is proud to partner with these leading medical societies and congresses from around the world to bring you news and insight from virtual and live events.

New Partners COMING SOON.

EUROPEAN ACADEMY OF ALLERGY AND CLINICAL IMMUNOLOGY (EAACI)

XIV International Congress of Dermatology 2025

Medics4RareDiseases

Urticaria Centers of Reference and Excellence (UCARE)

touchDERMATOLOGY touchDERMATOLOGY

Register Now!

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

  • Save your progress for video
  • Keep track of your CME credits
  • Add personalised learning notes
  • Receive updates from course leaders and faculty
  • Be the first to hear about new and exciting interactive learning opportunities

Latest articles videos and clinical updates - straight to your inbox

Close Popup